Log in

LON:HZDHorizon Discovery Group Share Price, Forecast & News

GBX 108.50
+7.50 (+7.43 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
100
Now: GBX 108.50
110.50
50-Day Range
98.60
MA: GBX 108.84
131
52-Week Range
96
Now: GBX 108.50
186.80
Volume1.46 million shs
Average Volume258,981 shs
Market Capitalization£170.90 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Horizon Discovery Group plc designs, manufactures, and applies gene editing and gene modulation to build cell models that harbour the genetics of human disease in the Americas, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Products, Services, and Leveraged Research and Development (R&D) segments. It operates a transnational genomics platform, a suite of gene editing tools to alter gene sequence in human or mammalian cell-lines. The company offers various research products, including cell lines that help researchers to understand how complex genetic diseases manifest themselves in patients; research reagents, which enable researchers to silence genes with the use of RNAi and express or overexpress genes through tools, such as cDNA, as well as permanently edit genes with CRISPR reagents; and in vivo research models for specialized R&D applications, and to support preclinical drug development programs. It also provides reference standards that are used as a source of genetically defined, quantitative, sustainable, and independent third-party reference material, as well as for validation and routine performance monitoring of assays; and bio-production cell lines licenses. In addition, the company offers cell and in vivo custom model generation, assay, and genetic and molecular screening services, as well as screening publications. Further, it is involved in the leverages R&D activity. The company serves customers in academic research, drug discovery and manufacturing, and clinical diagnostics markets. It sells its products through direct sales channel and e-commerce platform. The company has a partnership with C4X Discovery Holdings plc to validate novel synthetic oncology targets; and the Rutgers, The State University of New Jersey to develop and commercialize base editing, a gene editing technology. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.
Read More
Horizon Discovery Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.94 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1223-976000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£58.25 million
Cash FlowGBX 13.67 per share
Book ValueGBX 84.30 per share

Profitability

Miscellaneous

Employees288
Market Cap£170.90 million
Next Earnings DateN/A
OptionableNot Optionable

Receive HZD News and Ratings via Email

Sign-up to receive the latest news and ratings for HZD and its competitors with MarketBeat's FREE daily newsletter.

Horizon Discovery Group (LON:HZD) Frequently Asked Questions

How has Horizon Discovery Group's stock been impacted by COVID-19 (Coronavirus)?

Horizon Discovery Group's stock was trading at GBX 132 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HZD shares have decreased by 17.8% and is now trading at GBX 108.50. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Horizon Discovery Group?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Horizon Discovery Group in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Horizon Discovery Group.

What price target have analysts set for HZD?

3 equities research analysts have issued 1 year price objectives for Horizon Discovery Group's shares. Their forecasts range from GBX 170.80 to GBX 280. On average, they anticipate Horizon Discovery Group's stock price to reach GBX 207.20 in the next twelve months. This suggests a possible upside of 91.0% from the stock's current price. View analysts' price targets for Horizon Discovery Group.

Has Horizon Discovery Group been receiving favorable news coverage?

Press coverage about HZD stock has been trending extremely negative on Sunday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Horizon Discovery Group earned a coverage optimism score of -4.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutHorizon Discovery Group.

Who are some of Horizon Discovery Group's key competitors?

What other stocks do shareholders of Horizon Discovery Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Horizon Discovery Group investors own include Flowgroup (FLOW), Crispr Therapeutics (CRSP), Faron Pharmaceuticals Oy (FARN), Yamana Gold (YRI), Barkerville Gold Mines (BGM), Celgene (CELG), Eldorado Gold (ELD), Games Workshop Group (GAW), Polo Resources (POL) and Silvercorp Metals (SVM).

Who are Horizon Discovery Group's key executives?

Horizon Discovery Group's management team includes the following people:
  • Mr. Terence William Pizzie, CEO & Director (Age 58)
  • Dr. Chris Torrance, Co-Founder & Member of Scientific Advisory Board
  • Prof. Alberto Bardelli, Co-Founder & Chairman of Scientific Advisory Board
  • Mr. Jayesh Pankhania, CFO & Director
  • Ms. Kim Nichols, Head of Global Operations

What is Horizon Discovery Group's stock symbol?

Horizon Discovery Group trades on the London Stock Exchange (LON) under the ticker symbol "HZD."

How do I buy shares of Horizon Discovery Group?

Shares of HZD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Horizon Discovery Group's stock price today?

One share of HZD stock can currently be purchased for approximately GBX 108.50.

How big of a company is Horizon Discovery Group?

Horizon Discovery Group has a market capitalization of £170.90 million and generates £58.25 million in revenue each year. Horizon Discovery Group employs 288 workers across the globe.

What is Horizon Discovery Group's official website?

The official website for Horizon Discovery Group is www.horizondiscovery.com.

How can I contact Horizon Discovery Group?

Horizon Discovery Group's mailing address is 8100 Cambridge Research Park Beach Drive, CAMBRIDGE, CB25 9TL, United Kingdom. The company can be reached via phone at +44-1223-976000.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.